InvestorsHub Logo

Justfactsmam

03/16/20 3:09 PM

#286735 RE: stevo99 #286732

...dont know if I would go that far...but certainly Coronavirus treatment/vaccine candidates seem to be the only ones holding up...

terrific speculative investment since proceeding with its planned Phase 2 clinical trial of Brilacidin in pill form, its defensin mimetic drug candidate with multi-indication potential, as a novel oral medication for the treatment of Ulcerative Colitis (UC) relatively soon after Coronavirus resolution.

BACK TO BACK HOMERUNS??? Looking at $40 ???

everything else is a "falling knife"